This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Niharika Sharma
Principal at Roivant Sciences


Dr. Niharika Sharma is a Principal embedded within the Corporate Development team based in Basel, Switzerland. She is focussed on external partnerships and internal acquisitions/divestitures. Previously as an Investment Associate at Roivant, she spearheaded European Asset Search and Evaluation efforts spanning the entire spectrum of clinical development in a therapeutic area agnostic manner. Prior to this, she was a part of Roivant’s Analyst program leading multiple projects ranging from clinical research to commercial due diligence for several vants such as Enzyvant, Immunovant and Axovant.

She holds a PhD in Immunology from Hannover Medical School, Germany and Karolinska Institute, Sweden, a M.Sc. in Immunology from King’s College London and B.Sc. in Biotechnology from Manipal School of Life Sciences, India.

Agenda Sessions

  • Startup Spotlight Pitch Competition